Why Merck Is A Better Dividend Stock Than Gilead Sciences

We last analyzed Merck & Co., Inc. (NYSE: MRK ) stock on May 22 in an article titled “Merck & Co. Stock: Inventory Doesn't Lie.” The article focused on the demand inAs you can tell, our core style is to provide actionable and unambiguous ideas from our independent research. If your share this investment style, check out Envision Early Retirement. It provides at least 1x in-depth articles per week on such ideas.We have helped our members not only to beat S&P 500 but also avoid heavy drawdowns despite the ext ...